Email this article to a friend
From basic research to clinical development of MEK1/2 inhibitors for cancer therapy
-
* Corresponding author: Sylvain Meloche sylvain.meloche@umontreal.ca
Journal of Hematology & Oncology 2010, 3:8 doi:10.1186/1756-8722-3-8